Truncated TrkB: Beyond a dominant negative receptor
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 3×
“TrkB.tk+ contains a complex intracellular domain with a tyrosine rich catalytic region [76] and binding sites for Shc and PLCg [29].”
TrkB signalling pathways in LTP and learning
Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055
Pencea, V., Bingaman, K. D., Wiegand, S. J., & Luskin, M. B. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06706.2001 · Cited by 927 · cited 3×
“The direct effects of BDNF on neurogenesis are not clear [39], but there is evidence supporting BDNF-induced neurogenesis in the subventricular zone of the olfactory bulb (SVZ) [40].”
InfluentialGSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity
Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., & Kaibuchi, K. (2005) · Cell · doi:10.1016/j.cell.2004.11.012 · Cited by 875
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 1×
“Gene mutations and abnormal protein expression of BDNF are associated with neurological and psychiatric disorders including: schizophrenia, post traumatic stress disorder, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease [2–6].”
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867 · cited 1×
“For a review on the current therapeutic uses of BDNF, see [16].”
Middlemas, D. S., Lindberg, R. A., & Hunter, T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.143 · Cited by 775
Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.
Erickson, K. I., Prakash, R. S., Voss, M. W., Chaddock, L., Heo, S., McLaren, M., Pence, B. D., Martin, S. A., Vieira, V. J., Woods, J. A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6251-09.2010 · Cited by 604 · cited 1×
“BDNF signaling regulates (1) physiological proliferation during embryonic development [32–34], (2) sensory and motor neuron survival and growth rate [32,35,36], and (3) cortical and hippocampal health [37,38].”
trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development.
Klein, R., Parada, L. F., Coulier, F., & Barbacid, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08545.x · Cited by 598 · cited 1×
“[67,69,70].”
BDNF function and intracellular signaling in neurons.
Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., & Kunugi, H. (2010) · PubMed · doi:10.14670/hh-25.237 · Cited by 597 · cited 4×
“tk to induce differentiation, proliferation and survival [1].”
Influential
Cited by
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298
TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258
BDNF isoforms: a round trip ticket between neurogenesis and serotonin?
Foltran, R. B., & Diaz, S. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13658 · Cited by 187
“Nevertheless, given that the distribution of T1 is abundant in the brain, highly regulated, region specific and increases with age, it was proposed that this form cannot act only as a dominant negative inhibitor, but has its own active signaling pathway (Fenner 2012).”
Lin, T.-W., Shih, Y.-H., Chen, S.-J., Lien, C.-H., Chang, C.-Y., Huang, T.-Y., Chen, S.-H., Jen, C. J., & Kuo, Y.-M. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.12.005 · Cited by 153
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Deinhardt, K., & Chao, M. V. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_5 · Cited by 147
Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.014 · Cited by 116
Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem
Popova, N. K., & Naumenko, V. S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1572747 · Cited by 105
“It is translated from the same gene as TrkB receptor, but alternative splicing removes the exons encoding the intracellular tyrosine kinase domain, making TrkB-T receptor functionally different [68].”
BackgroundInfluentialDysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes
Colombo, E., Triolo, D., Bassani, C., Bedogni, F., Di Dario, M., Dina, G., Fredrickx, E., Fermo, I., Martinelli, V., Newcombe, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025804118 · Cited by 52
Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46
“The two other isoforms associated with AD, TrkB-T1 and the TrkB-T-Shc, are characterized by a truncation of the intracellular tail, and lack the intracellular catalytic domain (Fenner 2012; Ferrer et al. 1999; Stoilov et al. 2002).”
BackgroundTrkB neurotrophin receptor at the core of antidepressant effects, but how?
Rantamäki, T. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02985-6 · Cited by 45
Metadata
- Authors
- Fenner, B. M.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 23
- Issue
- 1-2
- Pages
- 15-24
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W1963539721
- Cited by
- 211
- References
- 106
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.